• Type:
  • Category:

Celon Pharma SA: Investor Relations & Financial Insights | seat11a

red bg - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%

Celon Pharma S.A. Investor Relations:
Your Hub for Financial Insights and Updates

Quick Video Briefs

mobile 16 9 - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
Vimeo

By loading the video, you agree to our Terms & Conditions,
our Privacy Policy and Vimeo's privacy policy.

Load video

Celon Pharma S.A.

Ogrodowa 2a

05-092 Łomianki/Kiełpin, Poland

phone +48 5190 66531

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. 

red bg - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
line 1 - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
Celon Pharma S.A.

Video Hub

line 2 - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
red bg - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
line 1 - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%
Celon Pharma S.A.

At a Glance

line 2 - Celon Pharma SA: Investor Relations & Financial Insights | seat11a -%sitename%

About Celon Pharma S.A.

Celon Pharma S.A. is an integrated pharmaceutical company which conducts advanced research and manufactures modern drugs. The company is also a successful marketing authorisation holder for its products. The drugs we offer help thousands of patients lead a better and longer life.


Research and Development at Celon Pharma S.A.


Key Advantage: Robust R&D Facilities

One huge advantage of Celon Pharma S.A. is its strong research and development facilities which allow us to create whole new classes of effective drugs.


Expertise in the R&D Team

The research and development department in Celon Pharma S.A. employs over 160 scientists, of which one in four have PhD titles in molecular biology, pharmacy, or chemistry.


Investment in Innovative Pharmaceutical Products

We invest in the development of innovative pharmaceutical products which have the potential to treat cancers, neurological diseases, diabetes, and other metabolic disorders.

(c) seat11a – Publicly Listed Companies: Elevator Pitch, Deep-Dive, Financial Results, and ESG 

Unlock the insights of top publicly listed companies with seat11a.com

Elevate your understanding with powerful Elevator Pitches, Deep-Dive Presentations, and in-depth Financial Analysis

Scroll to top